LRRC6 Antikörper (Middle Region)
-
- Target Alle LRRC6 Antikörper anzeigen
- LRRC6 (Leucine Rich Repeat Containing 6 (LRRC6))
-
Bindungsspezifität
- AA 186-215, Middle Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LRRC6 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Flow Cytometry (FACS), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody recognizes Human LRRC6 (Center).
- Aufreinigung
- Protein A column, followed by peptide affinity purification
- Immunogen
- KLH conjugated synthetic peptide between 186-215 amino acids from the Central region of human LRRC6
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product LRRC6 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- LRRC6 (Leucine Rich Repeat Containing 6 (LRRC6))
- Andere Bezeichnung
- LRRC6 (LRRC6 Produkte)
- Synonyme
- LRTP antikoerper, Lrtp antikoerper, Tslrp antikoerper, CILD19 antikoerper, TSLRP antikoerper, lrrc6l antikoerper, leucine rich repeat containing 6 (testis) antikoerper, leucine rich repeat containing 6 antikoerper, Lrrc6 antikoerper, LRRC6 antikoerper, lrrc6 antikoerper
- Hintergrund
- LRRC6 may be involved in spermatocytogenesis or prophase of meiosis (By similarity).Synonyms: LRTP, Leucine-rich repeat-containing protein 6, Leucine-rich testis-specific protein, TSLRP, Testis-specific leucine-rich repeat protein
- Molekulargewicht
- 54255 Da
- Gen-ID
- 23639
- NCBI Accession
- NP_036604
- Pathways
- M Phase
-